231 related articles for article (PubMed ID: 19423346)
1. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Quezada E; Picciau C; Delogu G; Orallo F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2009 Jun; 19(12):3268-70. PubMed ID: 19423346
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
[TBL] [Abstract][Full Text] [Related]
3. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.
Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L; Viña D
Bioorg Med Chem Lett; 2011 Jul; 21(14):4224-7. PubMed ID: 21684743
[TBL] [Abstract][Full Text] [Related]
4. New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Janeiro P; Borges F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2010 Sep; 20(17):5157-60. PubMed ID: 20659799
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors.
Abdelhafez OM; Amin KM; Ali HI; Abdalla MM; Batran RZ
J Med Chem; 2012 Dec; 55(23):10424-36. PubMed ID: 23153282
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
[TBL] [Abstract][Full Text] [Related]
9. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study.
Matos MJ; Vilar S; Gonzalez-Franco RM; Uriarte E; Santana L; Friedman C; Tatonetti NP; Viña D; Fontenla JA
Eur J Med Chem; 2013 May; 63():151-61. PubMed ID: 23474901
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
12. 8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studies.
Viña D; Matos MJ; Ferino G; Cadoni E; Laguna R; Borges F; Uriarte E; Santana L
ChemMedChem; 2012 Mar; 7(3):464-70. PubMed ID: 22287164
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.
Chimenti F; Secci D; Bolasco A; Chimenti P; Bizzarri B; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 Apr; 52(7):1935-42. PubMed ID: 19267475
[TBL] [Abstract][Full Text] [Related]
15. Insight into the functional and structural properties of 3-arylcoumarin as an interesting scaffold in monoamine oxidase B inhibition.
Matos MJ; Vilar S; García-Morales V; Tatonetti NP; Uriarte E; Santana L; Viña D
ChemMedChem; 2014 Jul; 9(7):1488-500. PubMed ID: 24715707
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
[TBL] [Abstract][Full Text] [Related]
17. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.
Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B
Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252
[TBL] [Abstract][Full Text] [Related]
18. Alkynyl-coumarinyl ethers as MAO-B inhibitors.
Mertens MD; Hinz S; Müller CE; Gütschow M
Bioorg Med Chem; 2014 Mar; 22(6):1916-28. PubMed ID: 24560738
[TBL] [Abstract][Full Text] [Related]
19. Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies.
Carotti A; Carrieri A; Chimichi S; Boccalini M; Cosimelli B; Gnerre C; Carotti A; Carrupt PA; Testa B
Bioorg Med Chem Lett; 2002 Dec; 12(24):3551-5. PubMed ID: 12443774
[TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase inhibitory coumarin from Zanthoxylum schinifolium.
Jo YS; Huong DT; Bae K; Lee MK; Kim YH
Planta Med; 2002 Jan; 68(1):84-5. PubMed ID: 11842339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
